Cellular actions of beta-amyloid precursor protein and its soluble and fibrillogenic derivatives

Cited by (999)

Items 101–200 of 999

1. Natural products against Alzheimer's disease: Pharmaco-therapeutics and biotechnological interventions
   Abhijit Dey, Raktim Bhattacharya, Anuradha Mukherjee, Devendra Kumar Pandey · 2016 · Biotechnology Advances
2. Glaucoma ocular Alzheimer s disease
   Stuart J. McKinnon · 2003 · Frontiers in bioscience
3. Fresh and globular amyloid β protein (1–42) induces rapid cellular degeneration: evidence for AβP channel‐mediated cellular toxicity
   Rajinder Bhatia, Hai Lin, Ratneshwar Lal · 2000 · The FASEB Journal
4. Alterations in cerebral blood flow and glucose utilization in mice overexpressing the amyloid precursor protein
   Niwa, Kiyoshi, Kazama, Ken, Younkin, Steven G., Carlson, George A., Iadecola, Costantino · 2002 · Neurobiology of Disease
5. Toxicity of Amyloid β Peptide: Tales of Calcium, Mitochondria, and Oxidative Stress
   Laura Canevari, Andrey Y. Abramov, Michael R. Duchen · 2004 · Neurochemical Research
6. Regulation of Amyloid Precursor Protein Cleavage
   Julia Mills, Peter B. Reiner · 1999 · Journal of Neurochemistry
7. Calbindin D28k blocks the proapoptotic actions of mutant presenilin 1: Reduced oxidative stress and preserved mitochondrial function
   Qing Guo, Sylvia Christakos, Nic Robinson, Mark P. Mattson · 1998 · Proceedings of the National Academy of Sciences
8. Homodimerization of Amyloid Precursor Protein and Its Implication in the Amyloidogenic Pathway of Alzheimer's Disease
   Stefan Scheuermann, Boris Hambsch, Lars Hesse, Joachim Stumm, Carsten Schmidt, Dirk Beher, Thomas A. Bayer, Konrad T. Beyreuther, Gerd Multhaup · 2001 · Journal of Biological Chemistry
9. Increased Sensitivity to Mitochondrial Toxin-Induced Apoptosis in Neural Cells Expressing Mutant Presenilin-1 Is Linked to Perturbed Calcium Homeostasis and Enhanced Oxyradical Production
   Jeffrey N. Keller, Qing Guo, Frederick W. Holtsberg, Annadora J. Bruce‐Keller, Mark P. Mattson · 1998 · Journal of Neuroscience
10. Traumatic brain injury and Alzheimer's disease: a review
    Corinna van den Heuvel, Emma Thornton, Robert Vink · 2007 · Progress in brain research
11. The Transcriptionally Active Amyloid Precursor Protein (APP) Intracellular Domain Is Preferentially Produced from the 695 Isoform of APP in a β-Secretase-dependent Pathway
    Nikolai D. Belyaev, Katherine A. B. Kellett, Caroline Beckett, Natalia Z. Makova, Timothy J. Revett, Natalia N. Nalivaeva, Nigel M. Hooper, Anthony J. Turner · 2010 · Journal of Biological Chemistry
12. Role of p38/MAPKs in Alzheimer's Disease: Implications for Amyloid Beta Toxicity Targeted Therapy
    Kheiri, Ghazaleh, Dolatshahi, Mahsa, Rahmani, Farzaneh, Rezaei, Nima · 2018 · Reviews in the Neurosciences
13. Mitochondrial Dysfunction: Different Routes to Alzheimer’s Disease Therapy
    Pasquale Picone, Domenico Nuzzo, Luca Caruana, Valeria Scafidi, Marta Di Carlo · 2014 · Oxidative Medicine and Cellular Longevity
14. Transcranial magnetic stimulation as a therapeutic tool in psychiatry: what do we know about the neurobiological mechanisms?
    Anke Post, Martin Ekkehard Keck · 2001 · Journal of Psychiatric Research
15. Extracellular vesicles – Their role in the packaging and spread of misfolded proteins associated with neurodegenerative diseases
    Coleman, Bradley M., Hill, Andrew F. · 2015 · Seminars in Cell & Developmental Biology
16. Aβ-peptides enhance vasoconstriction in cerebral circulation
    Niwa, Kiyoshi, Porter, Valerie A., Kazama, Ken, Cornfield, David, Carlson, George A., Iadecola, Costantino · 2001 · American Journal of Physiology-Heart and Circulatory Physiology
17. Amyloid beta ion channel: 3D structure and relevance to amyloid channel paradigm
    Ratnesh Lal, Hai Lin, Arjan Pieter Quist · 2007 · Biochimica et Biophysica Acta (BBA) - Biomembranes
18. Donepezil-based multi-functional cholinesterase inhibitors for treatment of Alzheimer's disease
    Qi Li, Siyu He, Yao Chen, Feng Feng, Wei Qu, Haopeng Sun · 2018 · European Journal of Medicinal Chemistry
19. Neuronal overexpression of APPL, the Drosophila homologue of the amyloid precursor protein (APP), disrupts axonal transport
    Torroja, Laura, Chu, Hsin, Kotovsky, Irina, White, Kalpana · 1999 · Current Biology
20. Amyloid β‐peptide(1–42) and hydrogen peroxide‐induced toxicity are mediated by TRPM2 in rat primary striatal cultures
    Elena Fonfría, Ian C. B. Marshall, Izzy Boyfield, Stephen D. Skaper, Jane P. Hughes, Davina E. OWEN, W. Zhang, Barbara A. Miller, Christopher D. Benham, Shaun McNulty · 2005 · Journal of Neurochemistry
21. An endoplasmic-reticulum-specific apoptotic pathway is involved in prion and amyloid-beta peptides neurotoxicity
    Elisabete B. Ferreiro, Rosa Resende, Rui O. Costa, Catarina Resende Oliveira, Cláudia Pereira · 2006 · Neurobiology of Disease
22. Increased Vulnerability of Hippocampal Neurons from Presenilin‐1 Mutant Knock‐In Mice to Amyloid β‐Peptide Tox: Central Roles of Superoxide Production and Caspase Activation
    Guo, Qing, Sebastian, Lois, Sopher, Bryce L., Miller, Miles W., Ware, Carol B., Martin, George M., Mattson, Mark P. · 1999 · Journal of Neurochemistry
23. Secreted β-Amyloid Precursor Protein Counteracts the Proapoptotic Action of Mutant Presenilin-1 by Activation of NF-κB and Stabilization of Calcium Homeostasis
    Guo, Qing, Robinson, Nic, Mattson, Mark P. · 1998 · Journal of Biological Chemistry
24. Aβ ion channels. Prospects for treating Alzheimer's disease with Aβ channel blockers
    Nelson J. Arispe, Juan Carlos Díaz, Olga Šimáková · 2007 · Biochimica et Biophysica Acta (BBA) - Biomembranes
25. Exogenous Aβ1–40 Reproduces Cerebrovascular Alterations Resulting from Amyloid Precursor Protein Overexpression in Mice
    Niwa, Kiyoshi, Carlson, George A., Iadecola, Costantino · 2000 · Journal of Cerebral Blood Flow & Metabolism
26. Apoptosis and Alzheimer's disease
    Christian Behl · 2000 · Journal of Neural Transmission
27. Soluble amyloid precursor protein-α modulates β-secretase activity and amyloid-β generation
    Obregon, Demian, Hou, Huayan, Deng, Juan, Giunta, Brian, Tian, Jun, Darlington, Donna, Shahaduzzaman, Md, Zhu, Yuyuan, Mori, Takashi, Mattson, Mark P. et al. · 2012 · Nature Communications
28. A Critical Review of Vitamin C for the Prevention of Age-Related Cognitive Decline and Alzheimer's Disease
    Fiona Edith Harrison · 2012 · Journal of Alzheimer s Disease
29. Animal models of Alzheimer's disease and evaluation of anti-dementia drugs
    Kiyofumi Yamada, Toshitaka Nabeshima · 2000 · Pharmacology & Therapeutics
30. The presenilin-1 familial Alzheimer disease mutant P117L impairs neurogenesis in the hippocampus of adult mice
    Paul H. Wen, Patrick R. Hof, Xiaoping Chen, Karen Gluck, Gregory Austin, Steven G. Younkin, Linda H. Younkin, Rita DeGasperi, Miguel A. Gama Sosa, Nikolaos K. R K Robakis et al. · 2004 · Experimental Neurology
31. Amyloid precursor protein (APP) regulates synaptic structure and function
    Tyan, Sheue-Houy, Shih, Ann Yu-Jung, Walsh, Jessica J., Maruyama, Hiroko, Sarsoza, Floyd, Ku, Lawrence, Eggert, Simone, Hof, Patrick R., Koo, Edward H., Dickstein, Dara L. · 2012 · Molecular and Cellular Neuroscience
32. Green Tea Epigallocatechin-3-Gallate (EGCG) and Other Flavonoids Reduce Alzheimer's Amyloid-Induced Mitochondrial Dysfunction
    Natasa Dragicevic, Adam Smith, Xiaoyang Lin, Fang Yuan, Neil Copes, Vedad Delic, Jun Tan, Chuanhai Cao, R. Douglas Shytle, Patrick C. Bradshaw · 2011 · Journal of Alzheimer s Disease
33. Staging of Cytoskeletal and β-Amyloid Changes in Human Isocortex Reveals Biphasic Synaptic Protein Response during Progression of Alzheimer’s Disease
    Elizabeta B. Mukaetova‐Ladinska, Francisco García‐Sierra, Jenny Hurt, Herman-J. Gertz, John H. Xuereb, Richard Hills, Carol Brayne, Felicia A. Huppert, Eugene S. Paykel, Magnus A. McGee et al. · 2000 · American Journal Of Pathology
34. Reduction of iron‐regulated amyloid precursor protein and β‐amyloid peptide by (–)‐epigallocatechin‐3‐gallate in cell cultures: implications for iron chelation in Alzheimer's disease
    Lydia Reznichenko, Tamar Amit, Hailin Zheng, Yael Avramovich‐Tirosh, Moussa B. H. Youdim, Orly Weinreb, Silvia A. Mandel · 2006 · Journal of Neurochemistry
35. New role of P2X7 receptor in an Alzheimer’s disease mouse model
    Martin, Elodie, Amar, Majid, Dalle, Carine, Youssef, Ihsen, Boucher, Céline, Le Duigou, Caroline, Brückner, Matthias, Prigent, Annick, Sazdovitch, Véronique, Halle, Annett et al. · 2019 · Molecular Psychiatry
36. The Catalytic Subunit of Telomerase Is Expressed in Developing Brain Neurons and Serves a Cell Survival-Promoting Function
    Weiming Fu, Michael W. Killen, Carsten Culmsee, Sonu Dhar, Tej Krishan Pandita, Mark P. Mattson · 2000 · Journal of Molecular Neuroscience
37. Anti-amyloidogenic effects of antioxidants: Implications for the prevention and therapeutics of Alzheimer's disease
    Kenjiro Ono, Tsuyoshi Hamaguchi, Hironobu Naiki, Masahito Yamada · 2006 · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
38. Melatonin treatment restores mitochondrial function in Alzheimer’s mice: a mitochondrial protective role of melatonin membrane receptor signaling
    Natasa Dragicevic, Neil Copes, Gina O’Neal-Moffitt, Jingji Jin, Robert W. Buzzeo, Maggie Mamcarz, Jun Tan, Chuanhai Cao, James Olcese, Gary W. Arendash et al. · 2011 · Journal of Pineal Research
39. Use-Dependent Effects of Amyloidogenic Fragments of β-Amyloid Precursor Protein on Synaptic Plasticity in Rat HippocampusIn Vivo
    Joung‐Hun Kim, Roger Anwyl, Yoo‐Hun Suh, Mustafa B.A. Djamgoz, Michael J. Rowan · 2001 · Journal of Neuroscience
40. Peptidyl-prolyl cis–trans isomerase Pin1 in ageing, cancer and Alzheimer disease
    Tae Ho Lee, Lucia Pastorino, Kun Ping Lu · 2011 · Expert Reviews in Molecular Medicine
41. Molecular Dissection of the Interaction between Amyloid Precursor Protein and Its Neuronal Trafficking Receptor SorLA/LR11
    Andersen, Olav M., Schmidt, Vanessa, Spoelgen, Robert, Gliemann, Jørgen, Behlke, Joachim, Galatis, Denise, McKinstry, William J., Parker, Michael W., Masters, Colin L., Hyman, Bradley T. et al. · 2006 · Biochemistry
42. Autophagy protects neuron from Aβ-induced cytotoxicity
    Shih‐Ya Hung, Wei‐Pang Huang, Houng‐Chi Liou, Wen Fu · 2009 · Autophagy
43. Neprilysin-sensitive Synapse-associated Amyloid-β Peptide Oligomers Impair Neuronal Plasticity and Cognitive Function
    Shu-Ming Huang, Akihiro Mouri, Hideko Kokubo, Ryuichi Nakajima, Takahiro Suemoto, Makoto Higuchi, Matthias Staufenbiel, Yukihiro Noda, Haruyasu Yamaguchi, Toshitaka Nabeshima et al. · 2006 · Journal of Biological Chemistry
44. β-Amyloid Causes Depletion of Synaptic Vesicles Leading to Neurotransmission Failure
    Jorge Parodí, Fernando J. Sepúlveda, Jorge Roa, Carlos Opazo, Nibaldo C. Inestrosa, Luis Gerardo Aguayo · 2009 · Journal of Biological Chemistry
45. Dysregulation of Cellular Calcium Homeostasis in Alzheimer's Disease: Bad Genes and Bad Habits
    Mark P. Mattson, Sic L. Chan · 2001 · Journal of Molecular Neuroscience
46. Age-related neuropathology, cognitive decline, and Alzheimer's disease.
    J. Keller · 2006 · Ageing Research Reviews
47. Differences of peripheral inflammatory markers between mild cognitive impairment and Alzheimer's disease
    Bermejo, Paloma, Martín-Aragón, Sagrario, Benedí, Juana, Susín, Cristina, Felici, Emanuela, Gil, Pedro, Ribera, José Manuel, Villar, Ángel Mª · 2008 · Immunology Letters
48. Insulin regulates soluble amyloid precursor protein release via phosphatidyl inositol 3 kinase‐dependent pathway
    Daniela C. Solano, Marita Sironi, Claudia Bonfini, Sebastiano Bruno Solerte, Stefano M. Govoni, Marco Racchi · 2000 · The FASEB Journal
49. The Catalytic Subunit of Telomerase Protects Neurons Against Amyloid β‐Peptide‐Induced Apoptosis
    Zhu, Haiyan, Fu, Weiming, Mattson, Mark P. · 2000 · Journal of Neurochemistry
50. hnRNP C promotes APP translation by competing with FMRP for APP mRNA recruitment to P bodies
    Eun Kyung Lee, Hyeon Ho Kim, Yuki Kuwano, Kotb Abdelmohsen, Subramanya Srikantan, Sarah S. Subaran, Marc Gleichmann, Mohamed R. Mughal, Jennifer L. Martindale, Xiaoling Yang et al. · 2010 · Nature Structural & Molecular Biology
51. Behavioral phenotypes of amyloid‐based genetically modified mouse models of Alzheimer's disease
    Dione T. Kobayashi, K. S. Chen · 2005 · Genes Brain & Behavior
52. Neurotoxic Mechanisms Caused by the Alzheimer's Disease-linked Swedish Amyloid Precursor Protein Mutation
    Celio A. Marques, Uta Keil, Astrid Bonert, Barbara Steiner, Christian Haass, Walter E. Müller, Anne Eckert · 2003 · Journal of Biological Chemistry
53. Suppression of brain aging and neurodegenerative disorders by dietary restriction and environmental enrichment: molecular mechanisms
    Mark P. Mattson · 2001 · Mechanisms of Ageing and Development
54. Presenilin-1 Mutation Increases Neuronal Vulnerability to Focal IschemiaIn Vivoand to Hypoxia and Glucose Deprivation in Cell Culture: Involvement of Perturbed Calcium Homeostasis
    Mark P. Mattson, Haiyan Zhu, Jin Yu, Mark S. Kindy · 2000 · Journal of Neuroscience
55. Soluble amyloid precursor protein α reduces neuronal injury and improves functional outcome following diffuse traumatic brain injury in rats
    Emma Thornton, Robert Vink, Peter Charles Blumbergs, Corinna van den Heuvel · 2006 · Brain Research
56. Salivary biomarkers for the diagnosis and monitoring of neurological diseases
    Raymond Farah, Hayat Haraty, Ziad Salame, Youssef Fares, David M. Ojcius, Najwane Said Sadier · 2018 · Biomedical Journal
57. Human Mesenchymal Stem Cells Express Neural Genes, Suggesting a Neural Predisposition
    N. Blondheim-Shraga, Yossef S. Levy, Tali Ben‐Zur, Alex Burshtein, Tirza Cherlow, Inna Kan, Ran Barzilai, Merav Bahat-Stromza, Yael Barhum, Shlomo Bulvik et al. · 2006 · Stem Cells and Development
58. Neuroplasticity in Alzheimer's disease
    Teter, Bruce, Ashford, J. Wesson · 2002 · Journal of Neuroscience Research
59. Calcium dysregulation in Alzheimer's disease: From mechanisms to therapeutic opportunities
    Jin‐Tai Yu, Raymond Chuen‐Chung Chang, Lan Tan · 2009 · Progress in Neurobiology
60. Dietary restriction protects hippocampal neurons against the death-promoting action of a presenilin-1 mutation
    Haiyan Zhu, Qing Guo, Mark P. Mattson · 1999 · Brain Research
61. (Peri)vascular production and action of pro-inflammatory cytokines in brain pathology
    Jan Pieter Konsman, Benjamin Drukarch, Anne‐Marie van Dam · 2006 · Clinical Science
62. Glycogen synthase kinase 3β and Alzheimer’s disease: pathophysiological and therapeutic significance
    Yokesh Balaraman, A. R. Limaye, Allan I. Levey, Shanthi Srinivasan · 2006 · Cellular and Molecular Life Sciences
63. Iron dysregulation in Alzheimer's disease: Multimodal brain permeable iron chelating drugs, possessing neuroprotective-neurorescue and amyloid precursor protein-processing regulatory activities as therapeutic agents
    Mandel, Silvia, Amit, Tamar, Bar-Am, Orit, Youdim, Moussa B.H. · 2007 · Progress in Neurobiology
64. Coupling energy metabolism with a mechanism to support brain-derived neurotrophic factor-mediated synaptic plasticity
    Shoshanna Vaynman, Zhe Ying, A. Wu, Fernando Gómez‐Pinilla · 2006 · Neuroscience
65. Catecholamines Potentiate Amyloid β-Peptide Neurotoxicity: Involvement of Oxidative Stress, Mitochondrial Dysfunction, and Perturbed Calcium Homeostasis
    Weiming Fu, Hong Luo, Sampath Parthasarathy, Mark P. Mattson · 1998 · Neurobiology of Disease
66. The roles of amyloid precursor protein (APP) in neurogenesis
    Zhidong Zhou, Christine Hui-shan Chan, Quanhong Ma, Xiaohong Xu, Zhi‐Cheng Xiao, Eng‐King Tan · 2011 · Cell Adhesion & Migration
67. Nonfibrillar diffuse amyloid deposition due to a gamma42-secretase site mutation points to an essential role for N-truncated Abeta42 in Alzheimer's disease
    Kumar-Singh, S. · 2000 · Human Molecular Genetics
68. Molecular mechanisms of brain aging and neurodegenerative disorders: Lessons from dietary restriction
    Prolla, Tomas A, Mattson, Mark P · 2001 · Trends in Neurosciences
69. Inflammatory mediators promote production of shed LRP1/CD91, which regulates cell signaling and cytokine expression by macrophages
    Matvey S. Gorovoy, Alban Gaultier, W. Marie Campana, Gary S. Firestein, Steven L. Gonias · 2010 · Journal of Leukocyte Biology
70. Potential role of presenilin-regulated signaling pathways in sporadic neurodegeneration
    Edward H. Koo, Raphael Kopan · 2004 · Nature Medicine
71. Amyloid-β Induces Chemotaxis and Oxidant Stress by Acting at Formylpeptide Receptor 2, a G Protein-coupled Receptor Expressed in Phagocytes and Brain
    H. Lee Tiffany, Mark C. Lavigne, You‐Hong Cui, Jiming Wang, Thomas L. Leto, Ji‐Liang Gao, Philip M. Murphy · 2001 · Journal of Biological Chemistry
72. Neuronal Gene Targets of NF-κB and Their Dysregulation in Alzheimer's Disease
    Wanda M. Snow, Benedict C. Albensi · 2016 · Frontiers in Molecular Neuroscience
73. The Neuroprotective Functions of Selenoprotein M and its Role in Cytosolic Calcium Regulation
    Mariclair A. Reeves, Frederick P. Bellinger, Marla J. Berry · 2009 · Antioxidants and Redox Signaling
74. Involvement of endoplasmic reticulum Ca2+ release through ryanodine and inositol 1,4,5‐triphosphate receptors in the neurotoxic effects induced by the amyloid‐β peptide
    Elisabete B. Ferreiro, Catarina Resende Oliveira, Cláudia Pereira · 2004 · Journal of Neuroscience Research
75. AlzPathway: a comprehensive map of signaling pathways of Alzheimer’s disease
    Satoshi Mizuno, Risa Iijima, Soichi Ogishima, Masataka Kikuchi, Yukiko Matsuoka, Samik Ghosh, Tadashi Miyamoto, Akinori Miyashita, Ryozo Kuwano, Hiroshi Tanaka · 2012 · BMC Systems Biology
76. Fresh and nonfibrillar amyloid β protein(1–40) induces rapid cellular degeneration in aged human fibroblasts: evidence for AβP‐channel‐mediated cellular toxicity
    Yinwen Judy Zhu, Hai Lin, Ratneshwar Lal · 2000 · The FASEB Journal
77. Vitamin A and Alzheimer's disease
    Kenjiro Ono, Masahito Yamada · 2011 · Geriatrics and gerontology international/Geriatrics & gerontology international
78. Mitoenergetic failure in Alzheimer disease
    Mordhwaj Singh Parihar, Gregory J. Brewer · 2006 · American Journal of Physiology-Cell Physiology
79. Spatial relationship between synapse loss and β‐amyloid deposition in Tg2576 mice
    Hongxin Dong, Maureen V. Martin, Shawn Chambers, John G. Csernansky · 2006 · The Journal of Comparative Neurology
80. The Mitochondrial Spiral: An Adequate Cause of Dementia in the Alzheimer's Syndrome
    John P. Blass · 2000 · Annals of the New York Academy of Sciences
81. Neuroinflammatory Signaling Upregulation in Alzheimer's Disease
    Walter J. Lukiw, Nicolas Guillermo Bazan · 2000 · Neurochemical Research
82. Folic acid and homocysteine in age-related disease
    Mark P. Mattson, Inna I. Kruman, Wenzhen Duan · 2002 · Ageing Research Reviews
83. Axonal transport, tau protein, and neurodegeneration in Alzheimer's disease
    Terwel, Dick, Dewachter, Ilse, Van Leuven, Fred · 2002 · NeuroMolecular Medicine
84. Multi-Target Directed Donepezil-Like Ligands for Alzheimer's Disease
    Mercedes Unzeta, Gerard Esteban, Irene Bolea, Wieslawa Agnieszka Fogel, Rona Ruth Ramsay, Moussa B. H. Youdim, Keith Francis Tipton, Jose Luis Marco · 2016 · Frontiers in Neuroscience
85. Oxidative Stress, Perturbed Calcium Homeostasis, and Immune Dysfunction in Alzheimer's Disease
    Mark P. Mattson · 2002 · Journal of NeuroVirology
86. Constitutive shedding of the amyloid precursor protein ectodomain is up-regulated by tumour necrosis factor-α converting enzyme
    Barbara E. Slack, K. Leona, Ching Ching Seah · 2001 · Biochemical Journal
87. Role of Hydrogen Peroxide in the Aetiology of Alzheimer??s Disease
    Nathaniel G.N. Milton · 2004 · Drugs & Aging
88. Brain cholinergic vulnerability: Relevance to behavior and disease
    Michael McKinney · 2005 · Biochemical Pharmacology
89. Prospective therapeutic applications of p53 inhibitors
    Andrei V. Gudkov, Elena A. Komarova · 2005 · Biochemical and Biophysical Research Communications
90. Pharmacology of AMPA/Kainate Receptor Ligands and Their Therapeutic Potential in Neurological and Psychiatric Disorders
    Gordon J. Lees · 2000 · Drugs
91. Inhibition of dynamin-dependent endocytosis increases shedding of the amyloid precursor protein ectodomain and reduces generation of amyloid β protein
    Robyn M Carey, Brigitte A Balcz, Ignacio López G.‐Coviella, Barbara E. Slack · 2005 · BMC Cell Biology
92. Integrin signaling via the PI3‐kinase–Akt pathway increases neuronal resistance to glutamate‐induced apoptosis
    Devin S. Gary, Mark P. Mattson · 2001 · Journal of Neurochemistry
93. Evidence for caspase‐mediated cleavage of AMPA receptor subunits in neuronal apoptosis and Alzheimer's disease
    Sic L. Chan, W. Sue T. Griffin, Mark P. Mattson · 1999 · Journal of Neuroscience Research
94. Urocortin, But Not Urocortin II, Protects Cultured Hippocampal Neurons from Oxidative and Excitotoxic Cell Death via Corticotropin-Releasing Hormone Receptor Type I
    Ward A. Pedersen, Ruiqian Wan, Peisu Zhang, Mark P. Mattson · 2002 · Journal of Neuroscience
95. Oxidative stress mediates the pathogenic effect of different Alzheimer’s disease risk factors
    Michela Guglielmotto · 2010 · Frontiers in Aging Neuroscience
96. The neuroprotective effect of pituitary adenylate cyclase-activating polypeptide on cerebellar granule cells is mediated through inhibition of the CED3-related cysteine protease caspase-3/CPP32
    David Vaudry, Bruno José Gonzalez, Magali Basille · 2000 · Proceedings of the National Academy of Sciences
97. Tau and Axonopathy in Neurodegenerative Disorders
    Higuchi, Makoto, Lee, Virginia M-Y, Trojanowski, John Q · 2002 · NeuroMolecular Medicine
98. A plasticity-based theory of the pathogenesis of Alzheimer's disease.
    MESULAM, M.‐MARSEL · 2000 · Annals of the New York Academy of Sciences
99. Aβ induces cell death by direct interaction with its cognate extracellular domain on APP (APP 597–624)
    Shaked, G. M., Kummer, M. P., Lu, D. C., Galvan, V., Bredesen, D. E., Koo, E. H., Shaked, G. M., Kummer, M. P., Lu, D. C., Galvan, V. et al. · 2006 · The FASEB Journal
100. Neuroprotective effects of icaritin against beta amyloid-induced neurotoxicity in primary cultured rat neuronal cells via estrogen-dependent pathway
     Zhenhai Wang, Xinyi Zhang, H. Wang, Qi Li, Yijia Lou · 2007 · Neuroscience